Oncogene - Table of Contents alert Volume 35 Issue 48

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 35, Issue 48 (December 2016) In this issue Review Original Articles Short Communication Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Review Top MDM2 oligomers: antagonizers of the guardian of the genome P L Leslie and Y Zhang Oncogene 2016 35: 6157-6165; advance online publication, April 4, 2016; 10.1038/onc.2016.88 Abstract | Full Text Original Articles Top The C/EBPδ protein is stabilized by estrogen receptor α activity, inhibits SNAI2 expression and associates with good prognosis in breast cancer D Mendoza-Villanueva, K Balamurugan, H R Ali, S-R Kim, S Sharan, R C Johnson, A S Merchant, C Caldas, G Landberg and E Sterneck Oncogene 2016 35: 6166-6176; advance online publication, May 16, 2016; 10.1038/onc.2016.156 Abstract | Full Text miR-135b, a key regulator of malignancy, is linked to poor prognosis in human myxoid liposarcoma OPEN Y Nezu, K Hagiwara, Y Yamamoto, T Fujiwara, K Matsuo, A Yoshida, A Kawai, T Saito and T Ochiya Oncogene 2016 35: 6177-6188; advance online publication, May 9, 2016; 10.1038/onc.2016.157 Abstract | Full Text MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1 L Venturutti, R I Cordo Russo, M A Rivas, M F Mercogliano, F Izzo, R H Oakley, M G Pereyra, M De Martino, C J Proietti, P Yankilevich, J C Roa, P Guzmán, E Cortese, D H Allemand, T H Huang, E H Charreau, J A Cidlowski, R Schillaci and P V Elizalde Oncogene 2016 35: 6189-6202; advance online publication, May 9, 2016; 10.1038/onc.2016.151 Abstract | Full Text The B-cell tumor promoter Bcl-3 suppresses inflammation-associated colon tumorigenesis in epithelial cells W Tang, H Wang, H L Ha, I Tassi, R Bhardwaj, E Claudio and U Siebenlist Oncogene 2016 35: 6203-6211; advance online publication, May 2, 2016; 10.1038/onc.2016.152 Abstract | Full Text Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia G B Martinelli, D Olivari, A D Re Cecconi, L Talamini, L Ottoboni, S H Lecker, C Stretch, V E Baracos, O F Bathe, A Resovi, R Giavazzi, L Cervo and R Piccirillo Oncogene 2016 35: 6212-6222; advance online publication, May 23, 2016; 10.1038/onc.2016.153 Abstract | Full Text FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma Y Li, M N Bouchlaka, J Wolff, K M Grindle, L Lu, S Qian, X Zhong, N Pflum, P Jobin, B S Kahl, J C Eickhoff, S M Wuerzberger-Davis, S Miyamoto, C J Thomas, D T Yang, C M Capitini and L Rui Oncogene 2016 35: 6223-6234; advance online publication, May 9, 2016; 10.1038/onc.2016.155 Abstract | Full Text Restoration of tumor suppression in prostate cancer by targeting the E3 ligase E6AP P J Paul, D Raghu, A-L Chan, T Gulati, L Lambeth, E Takano, M J Herold, J Hagekyriakou, R L Vessella, C Fedele, M Shackleton, E D Williams, S Fox, S Williams, S Haupt, C Gamell and Y Haupt Oncogene 2016 35: 6235-6245; advance online publication, September 19, 2016; 10.1038/onc.2016.159 Abstract | Full Text MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesis A Ghoochani, M A Schwarz, E Yakubov, T Engelhorn, A Doerfler, M Buchfelder, R Bucala, N E Savaskan and I Y Eyüpoglu Oncogene 2016 35: 6246-6261; advance online publication, May 9, 2016; 10.1038/onc.2016.160 Abstract | Full Text Short Communication Top Pathogenic Helicobacter pylori strains translocate DNA and activate TLR9 via the cancer-associated cag type IV secretion system M G Varga, C L Shaffer, J C Sierra, G Suarez, M B Piazuelo, M E Whitaker, J Romero-Gallo, U S Krishna, A Delgado, M A Gomez, J A D Good, F Almqvist, E P Skaar, P Correa, K T Wilson, M Hadjifrangiskou and R M Peek Oncogene 2016 35: 6262-6269; advance online publication, May 9, 2016; 10.1038/onc.2016.158 Abstract | Full Text Corrigendum Top Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia OPEN A B Lee-Sherick, K M Eisenman, S Sather, A McGranahan, P M Armistead, C S McGary, S A Hunsucker, J Schlegel, H Martinson, C Cannon, A K Keating, H S Earp, X Liang, D DeRyckere and D K Graham Oncogene 2016 35: 6270; advance online publication, September 5, 2016; 10.1038/onc.2016.295 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.